Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 bind to a single leucine-rich motif of TrkB
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
TrkB is a member of the Trk family of neurotrophin receptors. Its extracellular domain exhibits the same modular structure found in its homologs, TrkA and TrkC, consisting of an N-terminal LRM3 cassette and two immunoglobulin-like modules (Ig2 domain) adjacent to the membrane. The LRM3 cassette comprises two cysteine-rich clusters framing a tandem array of three leucine-rich motifs (LRMs). On the basis of the recent identification of a nerve growth factor (NGF) binding site within TrkA, the ability of the different structural entities within the extracellular domain of TrkB to bind the various neurotrophins was determined by using a recombinant receptor approach. Brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) bound to the LRM3 cassette of TrkB, whereas NGF did not. These binding characteristics evidently reflect in vivo specificities. A more precise mapping of the region(s) responsible for binding BDNF, NT-3, and NT-4 identified the second leucine-rich motif of TrkB as a functional unit capable of binding all three neurotrophins. The affinities and kinetics that this short stretch of amino acids exhibited with respect to the different neurotrophins were clearly akin to those observed for cells ectopically expressing TrkB receptors. With 24 amino acids determining the affinities and kinetics of the interactions with three different partners, the leucine-rich motif is strongly established as one of the most potent and flexible protein--protein interaction motifs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Mice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067
Requirement for BDNF in activity-dependent survival of cortical neurons
Ghosh, A., Carnahan, J., & Greenberg, M. E. (1994) · Science · doi:10.1126/science.7907431 · Cited by 989
Klein, R., Nanduri, V., Jing, S., Lamballe, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K. R., Reichardt, L. F., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90628-c · Cited by 958
Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB
Berkemeier, L. R., Winslow, J. W., Kaplan, D. R., Nikolics, K., Goeddel, D. V., & Rosenthal, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90287-a · Cited by 836
The changing scene of neurotrophic factors
Thoenen, H. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90097-e · Cited by 820
Soppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820
Ernfors, P., Ibáñez, C. F., Ebendal, T., Olson, L., & Persson, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5454 · Cited by 700
Ip, N. Y., Ibáñez, C. F., Nye, S. H., McClain, J., Jones, P. F., Gies, D. R., Belluscio, L., Le Beau, M. M., Espinosa, R., & Squinto, S. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3060 · Cited by 626
Cited by
Neurotrophin Signaling Through the P75 Neurotrophin Receptor
Roux, P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00016-3 · Cited by 717
Leucine-rich repeat glycoproteins of the extracellular matrix
Hocking, A. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90070-1 · Cited by 470
Wiesmann, C., Ultsch, M. H., Bass, S. H., & de Vos, A. M. (1999) · Nature · doi:10.1038/43705 · Cited by 415
Wehrman, T., He, X., Raab, B., Dukipatti, A., Blau, H., & Garcia, K. C. (2007) · Neuron · doi:10.1016/j.neuron.2006.09.034 · Cited by 314
Structural and functional diversity in the leucine-rich repeat family of proteins
Buchanan, S. G. S. C., & Gay, N. J. (1996) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(96)00003-x · Cited by 312
Trk Receptor Expression and Inhibition in Neuroblastomas
Brodeur, G. M., Minturn, J. E., Ho, R., Simpson, A. M., Iyer, R., Varela, C. R., Light, J. E., Kolla, V., & Evans, A. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1815 · Cited by 307
GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain
Duchemin, A., Ren, Q., Mo, L., Neff, N. H., & Hadjiconstantinou, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00831.x · Cited by 283
Regulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles
Vilar, M., & Mira, H. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00026 · Cited by 235
Jang, S.-W., Liu, X., Chan, C.-B., Weinshenker, D., Hall, R. A., Xiao, G., & Ye, K. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.010 · Cited by 144
“A more precise mapping of the regions responsible for binding BDNF, NT-3, and NT-4 identified the second LRM of TrkB as a functional unit capable of binding all three neurotrophins (Windisch et al., 1995).”
BackgroundKryl, D., Yacoubian, T., Haapasalo, A., Castren, E., Lo, D., & Barker, P. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05823.1999 · Cited by 44
Osborne, A., Wang, A. X. Z., Tassoni, A., Widdowson, P. S., & Martin, K. R. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.069 · Cited by 43
Metadata
- Authors
- Windisch, J. M., Marksteiner, R., Lang, M. E., Auer, B., & Schneider, R.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-09-05
- Volume
- 34
- Issue
- 35
- Pages
- 11256-11263
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2040279906
- Cited by
- 62
- References
- 9
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.